Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier

NCT06371235 is registered in ClinicalTrials.gov with CerbaXpert as lead sponsor.

NCT NCT06371235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Transmission of Anti-interferon Type 1 Alpha Autoantibodies From Mother to Child Via the Placental Barrier
Lead sponsor
CerbaXpert
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
March 31, 2027
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

woman suffering from a pathology frequently associated with the presence of these anti-autoantibodies type-i interferons